|

Hydroxychloroquine Clinical Trials

11 actively recruiting trials across 5 locations

Also known as: HCQ, Plaquenil

Other5 trials

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
Phase 1/2
Immune-Mediated Pathophysiology And Clinical Triage Program
Phase 2
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Phase 2
The Clinical Efficacy of Immunomodulators in RA Patients
Phase 4
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
Phase 2/3

Philadelphia, Pennsylvania2 trials

A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Abramson Cancer Center at University of Pennsylvania

Phase 1/2
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer

Abramson Cancer Center of the University of Pennsylvania

Phase 2

Los Angeles, California1 trial

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

University of California, Los Angeles

Phase 3

Chicago, Illinois1 trial

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Northwestern University

Phase 2

Omaha, Nebraska1 trial

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

University of Nebraska Medical Center

Phase 3

Charleston, South Carolina1 trial

Autophagy Maintenance (AUTOMAIN)

Medical University of South Carolina

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.